Abstract:Optimal protein function often depends on co-operative interactions between amino acid residues distant in the protein primary sequence yet spatially near one another following protein folding. For example, antibody affinity is influenced by interactions of framework residues with complementarity-determining region (CDR) residues. However, despite the abundance of antibody structural information and computational tools the humanization of rodent antibodies for clinical use often results in a significant loss of affinity. To date, antibody engineering efforts have focused either on optimizing CDR residues involved in antigen binding or on optimizing antibody framework residues that serve critical roles in preserving the conformation of CDRs. In the present study a new approach which permits the rapid identification of co-operatively interacting framework and CDR residues was used to simultaneously humanize and optimize a murine antibody directed against CD40. Specifically, a combinatorial library that examined eight potentially important framework positions concomitantly with focused CDR libraries consisting of variants containing random single amino acid mutations in the third CDR of the heavy and light chains was expressed. Multiple anti-CD40 Fab variants containing as few as one murine framework residue and displaying up to approximately 500-fold higher affinity than the initial chimeric Fab were identified. The higher affinity humanized variants demonstrated a co-operative interaction between light chain framework residue Y49 and heavy chain CDR3 residue R/K101 (coupling energy, DeltaGI=0.9 kcal/mol). Screening of combinatorial framework-CDR libraries permits identification of monoclonal antibodies (mAb) with structures optimized for function, including instances in which the antigen induces conformational changes in the mAb. Moreover, the enhanced humanized variants contain fewer murine framework residues and could not be identified by sequential in vitro humanization and affinity muturation strategies. This approach to identifying co-operatively interacting residues is not restricted to antibody-antigen interactions and consequently, may be used broadly to gain insight into protein structure-function relationships, including proteins that serve as catalysts.

A New Approach For Rapidly Reshaping Single-Chain Antibody In Vitro By Combining Dna Shuffling With Ribosome Display

New Tetrapeptide Ligands Designed for Antibody Purification with Biomimetic Chromatography: Molecular Simulation and Experimental Validation

Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays.

Covalent and Oriented Immobilization of Scfv Antibody Fragments Via an Engineered Glycan Moiety

Design of a Novel Fab-Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use

Improvement of Antibody Affinity and Using PURE Ribosome Display and Microbial Secretion System

Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.

New protein engineering approaches to multivalent and bispecific antibody fragments

Atomically accurate de novo design of single-domain antibodies

Molecular Modeling and Affinity Determination of Scfv Antibody: Proper Linker Peptide Enhances Its Activity

Antibody Humanization By A Single Cycle Of Cdr-Grafting

Development and experimental validation of computational methods for human antibody affinity enhancement

Advancement in the development of single chain antibodies using phage display technology

Construction of Expression Vectors and Study on Single-Chain Antibody and Reshaping Single-Domain Antibody Against CD3

In vitro evolution of diagnostic antibodies targeting native antigens in plasma by sandwich flow cytometry

Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive

Construction of a fully synthetic human scFv antibody library with CDR3 regions randomized by a split-mix-split method and its application.

A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP Recombination

A computationally guided approach to improve expression of VHH binders

In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies

Engineered Fc Based Antibody Domains and Fragments As Novel Scaffolds.